We Treat Hep C

NEW THIS WEEK: New hepatitis C webinar training opportunity on Addressing Hepatitis C in Patients Struggling with Addiction added under Training + Resources tab on provider webpage

 

We Treat Hep C

The Michigan Department of Health and Human Services and Michigan Medicaid partnered with research-based global biopharmaceutical company, AbbVie, in effort to eliminate hepatitis C through the We Treat Hep C Initiative.

Effective April 1, 2021 the antiviral MAVYRET® will no longer require prior authorization. Other direct-acting antivirals will require prior authorization and will be approved only when MAVYRET® is not clinically appropriate.  


Resources for Providers
Resources for the Public